/

Crizotinib

CAS 877399-52-5

Overview

Crizotinib is an anti-cancer drug acting as an ALK and ROS1 inhibitor, approved for treatment of some non-small cell lung carcinoma in the US and some other countries, and undergoing clinical trials

Anant Labs manufacture and furnish high quality Crizotinib impurities for global markets. Our Crizotinib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

Active Pharmaceutical Ingredient

Chemical structure of Crizotinib

Crizotinib

Cat. No.: ANT-CZT-00
CAS: 877399-52-5
Mol. Formula: C₂₁H₂₂Cl₂FN₅O
Mol. Weight: 450.34

Impurities (5)

Chemical structure of Crizotinib Bromide Impurity

Crizotinib Bromide Impurity

Cat. No.: ANT-CZT-02
CAS: 877399-00-3
Mol. Formula: C₁₃H₁₀BrCl₂FN₂O
Mol. Weight: 380.04

Chemical structure of Crizotinib Impurity 1

Crizotinib Impurity 1

Cat. No.: ANT-CZT-04
CAS: NA
Mol. Formula: C₂₅H₃₀Cl₂FN₅O₂
Mol. Weight: 522.45

Chemical structure of Crizotinib Impurity 2

Crizotinib Impurity 2

Cat. No.: ANT-CZT-05
CAS: 877400-66-3
Mol. Formula: C₂₄H₂₈Cl₂FN₅O
Mol. Weight: 492.42

Chemical structure of Crizotinib N-Boc Crizotinib impurity

Crizotinib N-Boc Crizotinib impurity

Cat. No.: ANT-CZT-03
CAS: 877399-51-4
Mol. Formula: C₂₆H₃₀Cl₂FN₅O₃
Mol. Weight: 550.45

Chemical structure of Crizotinib Pinacol boronate Impurity

Crizotinib Pinacol boronate Impurity

Cat. No.: ANT-CZT-01
CAS: 877399-74-1
Mol. Formula: C₁₉H₃₂BN₃O₄
Mol. Weight: 377.29